Y90 Radioembolization Liver Cancer Treatment
Y90 Radioembolization Liver Cancer Treatment is a serious and life-threatening disease that affects millions of people worldwide. It is the fourth leading cause of cancer-related deaths, with a survival rate of only 18% over five years. Fortunately, advances in medical technology and treatment options have made it possible to improve the prognosis and quality of life for patients with liver cancer.
Introduction Of Y90 Radioembolization Liver Cancer Treatment:
Y90 Radioembolization Liver Cancer Treatment One such treatment is Y90 radioembolization, a minimally invasive procedure that uses small beads containing radioactive material to target and destroy cancer cells in the liver. In this article, we will discuss the details of Y90 radioembolization, its benefits, risks, and effectiveness.
What is Y90 Radioembolization?
Y90 radioembolization, also known as selective internal radiation therapy (SIRT), is a type of liver cancer treatment that combines radiation therapy and embolization. It involves the injection of small beads, called microspheres, into the liver artery that supplies blood to the cancerous tissue. These microspheres contain a radioactive isotope called yttrium-90 (Y90), which emits radiation that kills cancer cells while sparing healthy liver tissue.
Y90 radioembolization is a minimally invasive procedure that is performed by an interventional radiologist using imaging guidance. The procedure usually takes 1-2 hours to complete and is done under local anesthesia. Patients typically go home the same day or the next day.
Benefits of Y90 Radioembolization:
Y90 radioembolization has several benefits over traditional cancer treatments, including:
- Minimally Invasive: Y90 radioembolization is a minimally invasive procedure that requires only a small incision in the groin area. This means less pain and a faster recovery time compared to surgery.
- Effective: Y90 radioembolization is an effective treatment for liver cancer. Studies have shown that it can shrink tumors and extend the survival of patients with advanced liver cancer.
- Targeted: Y90 radioembolization is a targeted treatment that delivers radiation directly to the cancerous tissue. This means less damage to healthy liver tissue and fewer side effects.
- Combined Treatment: Y90 radioembolization can be used in combination with other treatments, such as chemotherapy or surgery, to improve outcomes.
Risks of Y90 Radioembolization:
Like any medical procedure, Y90 radioembolization has some risks. These include:
- Radiation Exposure: Y90 radioembolization involves exposure to radiation, which can increase the risk of radiation-induced liver disease and other radiation-related complications.
- Nausea and Fatigue: Some patients may experience nausea and fatigue after the procedure, but these symptoms usually resolve within a few days.
- Infection: There is a small risk of infection at the site of the incision or where the microspheres are injected.
- Blood Clots: Y90 radioembolization can increase the risk of blood clots, particularly in patients with a history of blood clots or those who have undergone previous liver surgery.
Effectiveness of Y90 Radioembolization:
Y90 radioembolization is an effective treatment for liver cancer. Studies have shown that it can shrink tumors and extend the survival of patients with advanced liver cancer. In one study, patients who underwent Y90 radioembolization had a median survival of 10.5 months, compared to 7.9 months for those who received standard treatment.
Y90 radioembolization is also effective in treating liver cancer that has spread to other parts of the body, such as the lungs or bones. In one study, patients with liver cancer that had spread to the lungs who underwent Y90 radioembolization had a
Y90 Radioembolization Liver Cancer Treatment How Its Work?
Y90 radioembolization is a minimally invasive liver cancer treatment that uses small beads containing radioactive material to target and destroy cancer cells in the liver. It works by delivering a high dose of radiation directly to the tumor while sparing healthy liver tissue.
The procedure involves the following steps:
- Preparation: Before the procedure, the patient undergoes imaging tests such as computed tomography (CT) or magnetic resonance imaging (MRI) to determine the size, location, and number of tumors in the liver. The patient is also evaluated for their overall health and suitability for the procedure.
- Insertion of Catheter: The patient is given local anesthesia, and a catheter is inserted into the groin area. The catheter is threaded through the blood vessels and positioned in the hepatic artery, which supplies blood to the liver.
- Injection of Microspheres: Once the catheter is in place, small beads, called microspheres, containing the radioactive isotope Yttrium-90 (Y90) are injected into the hepatic artery. The microspheres travel through the blood vessels and become lodged in the small blood vessels surrounding the tumor.
- Radiation Therapy: The microspheres emit radiation that penetrates the cancerous tissue, destroying the cancer cells. The radiation is highly localized, meaning that it primarily affects the tumor and minimizes damage to healthy liver tissue.
- Monitoring: After the procedure, the patient is monitored for several hours to ensure that there are no complications. They may also undergo imaging tests to evaluate the effectiveness of the treatment.
The Y90 radioembolization procedure typically takes 1-2 hours to complete and is performed on an outpatient basis. The patient can go home the same day or the next day and is usually able to resume normal activities within a few days.
If you want to get amazing benefits by using this link
Y90 Radiatioembolization For A Farmington
Y90 Radioembolization For A Mammogram
Final Words:
Y90 radioembolization is a safe and effective treatment for liver cancer, particularly in patients who are not candidates for surgery or who have tumors that cannot be completely removed by surgery. It can also be used in combination with other treatments, such as chemotherapy or surgery, to improve outcomes.
Although Y90 radioembolization has some risks, such as radiation exposure and the risk of infection or blood clots, these are generally low and can be managed with appropriate monitoring and care. Overall, Y90 radioembolization offers a promising option for patients with liver cancer, providing a minimally invasive and targeted treatment that can improve outcomes and quality of life.